Considerations regarding nonhuman primate use in safety assessment of biopharmaceuticals.
about
Pioneering better science through the 3Rs: an introduction to the national centre for the replacement, refinement, and reduction of animals in research (NC3Rs)Object discrimination and reversal learning in infant and juvenile non-human primates in a non-clinical laboratoryDogs and monkeys in preclinical drug development: the challenge of reducing and replacing.Challenges and opportunities for the future of monoclonal antibody development: Improving safety assessment and reducing animal use.Of Men and Mice: Modeling the Fragile X Syndrome.
P2860
Considerations regarding nonhuman primate use in safety assessment of biopharmaceuticals.
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
Considerations regarding nonhuman primate use in safety assessment of biopharmaceuticals.
@en
Considerations regarding nonhuman primate use in safety assessment of biopharmaceuticals.
@nl
type
label
Considerations regarding nonhuman primate use in safety assessment of biopharmaceuticals.
@en
Considerations regarding nonhuman primate use in safety assessment of biopharmaceuticals.
@nl
prefLabel
Considerations regarding nonhuman primate use in safety assessment of biopharmaceuticals.
@en
Considerations regarding nonhuman primate use in safety assessment of biopharmaceuticals.
@nl
P2093
P2860
P356
P1476
Considerations regarding nonhuman primate use in safety assessment of biopharmaceuticals.
@en
P2093
Janice A Lansita
Kathryn Chapman
Leigh Ann Burns-Naas
Lorrene A Buckley
Marque D Todd
Pauline L Martin
P2860
P304
P356
10.1177/1091581811415875
P577
2011-10-01T00:00:00Z